Behind the scenes there are a number of advances that Patricia Flatley Brennan, RN, PhD, director of the National Library of Medicine, would like to see take place to make it easier to get literature into people's hands.
, RN, PhD, director of the National Library of Medicine, would like to see take place to make it easier to get literature into people's hands.
Behind the scenes there are a number of advances that Patricia Flatley Brennan
Transcript
What advances at the National Library of Medicine would you like to see during your tenure? What initiatives are you excited to implement?
Advances that I would like to see are really on the back end. It's not at all obvious to people how complicated it is to get the literature into the hands of someone. We started off with data files and we ahve large computers that help convert the information in those records to important indexing tags so people can find them, and then we make the presentation of the information in a way that is machine and human readable.
But behind the scenes there's hundreds of people and lots of specialized skill to make sure that we tag an article with the proper term so it can be found by someone else, so we can organize the literate in a proper way. So one of the advances that I would like to see happen is enough technological support so that we can know when human indexing is absolutely essential to make an article findable, but when machine learning can help us actually do that in a faster way so we can get the literature into the hands of people more quickly.
Now as we go into the future, and this relates to the innovation you asked, we're changing the information substrate of healthcare. So for almost 2 centures the National Library of Medicine has used the literature, formal text presentations, as our substrate for healthcare. So we provide information on discoveries. We provide information on best practices. But we're moving into a data-driven era where these thousands of streams of data from the human genome to the air you're breathing to the sounds around you, become a part of the story of you and your health. And as we move to a data-driven health environment, we have to modify both the way we index and organize information, make it discoverable, make it useful for individuals.
So we at the National Library of Medicine will be doing for data what we've been doing for the literature for centuries, which is store it safely, make it accessible, make it useful, and put a value-add on it.
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Rozanolixizumab Effective in Patients with MuSK MG, Analysis Shows
October 23rd 2024A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More